Genetics of congenital heart disease: The contribution of the noncoding regulatory genome

Journal of Human Genetics

Volumn 61, Issue 1, 2016, Pages 13-19

  Postma, Alex V ^a   Bezzina, Connie R ^a   Christoffels, Vincent M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CAUSAL ATTRIBUTION; COMPARATIVE GENOMIC HYBRIDIZATION; CONGENITAL HEART DISEASE; DEVELOPMENTAL GENE; ENHANCER REGION; EXOME; GENE IDENTIFICATION; GENE MUTATION; GENETIC TRAIT; GENETIC VARIABILITY; HUMAN; INHERITANCE; MOLECULAR GENETICS; MOLECULAR PATHOLOGY; NEXT GENERATION SEQUENCING; REGULATOR GENE; REGULATORY MECHANISM; REVIEW; CONGENITAL HEART MALFORMATION; GENE EXPRESSION REGULATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HIGH THROUGHPUT SEQUENCING; HUMAN GENOME; MUTATION; REGULATORY SEQUENCE;

ENHANCER ELEMENTS, GENETIC; EXOME; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HEART DEFECTS, CONGENITAL; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INHERITANCE PATTERNS; MUTATION; REGULATORY SEQUENCES, NUCLEIC ACID;

EID: 84955463542     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2015.98     Document Type: Review

References (82)

1. Van Der Bom, T., Bouma, B. J., Meijboom, F. J., Zwinderman, A. H., & Mulder, B. J. M. The prevalence of adult congenital heart disease, results from a systematic review and evidence based calculation. Am. Heart J. 164, 568-575 (2012).
2. McCulley, D. J., & Black, B. L. Transcription factor pathways and congenital heart disease. Curr. Top. Dev. Biol. 100, 253-277 (2012).
3. Bruneau, B. G. Signaling and transcriptional networks in heart development and regeneration. Cold Spring Harb. Perspect. Biol. 5, a008292 (2013).
4. Gilboa, S. M., Salemi, J. L., Nembhard, W. N., Fixler, D. E., & Correa, A. Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006. Circulation 122, 2254-2263 (2010).
5. Van Der Bom, T., Winter, M. M., Bouma, B. J., Groenink, M., Vliegen, H. W., Pieper, P. G., et al. Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial. Circulation 127, 322-330 (2013).
6. Koyak, Z., Harris, L., De Groot, J. R., Silversides, C. K., Oechslin, E. N., Bouma, B. J., et al. Sudden cardiac death in adult congenital heart disease. Circulation 26, 1944-1954 (2012).
7. Van Der Bom, T., Van Der Palen, R. L. F., Bouma, B. J., Van Veldhuisen, S. L., Vliegen, H. W., Konings, T. C., et al. Persistent neo-Aortic growth during adulthood in patients after an arterial switch operation. Heart 100, 1360-1365 (2014).
8. Van Der Bom, T., Zomer, A. C., Zwinderman, A. H., Meijboom, F. J., Bouma, B. J., & Mulder, B. J. M. The changing epidemiology of congenital heart disease. Nat. Rev. Cardiol. 8, 50-60 (2011).
9. Peyvandi, S., Ingall, E., Woyciechowski, S., Garbarini, J., Mitchell, L. E., & Goldmuntz, E. Risk of congenital heart disease in relatives of probands with conotruncal cardiac defects: an evaluation of 1, 620 families. Am. J. Med. Genet. A 164A, 1490-1495 (2014).
10. Andersen, T. A., Troelsen, K. D. L. L., & Larsen, L. A. Of mice and men: molecular genetics of congenital heart disease. Cell Mol. Life Sci. 71, 1327-1352 (2013).
11. Schott, J. J., Benson, D. W., Basson, C. T., Pease, W., Silberbach, G. M., Moak, J. P., et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 281, 108-111 (1998).
12. Garg, V., Kathiriya, I. S., Barnes, R., Schluterman, M. K., King, I. N., Butler, C. A., et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424, 443-447 (2003).
13. Garg, V., Muth, A. N., Ransom, J. F., Schluterman, M. K., Barnes, R., King, I. N., et al. Mutations in NOTCH1 cause aortic valve disease. Nature 437, 270-274 (2005).
14. Lalani, S. R., & Belmont, J. W. Genetic basis of congenital cardiovascular malformations. Eur. J. Med. Genet. 57, 402-413 (2014).
15. Fahed, A. C., Gelb, B. D., Seidman, J. G., & Seidman, C. E. Genetics of congenital heart disease: the glass half empty. Circ. Res. 112, 707-720 (2013).
16. Barnett, P., & Postma, A. V. Genetics of congenital heart disease: Beyond half-measures. Trends Cardiovasc. Med. 25, 302-304 (2014).
17. Ching, Y.-H., Ghosh, T. K., Cross, S. J., Packham, E. A., Honeyman, L., Loughna, S., et al. Mutation in myosin heavy chain 6 causes atrial septal defect. Nat. Genet. 37, 423-428 (2005).
18. Postma, A. V., Van Engelen, K., Van De Meerakker, J., Rahman, T., Probst, S., Baars, M. J. H., et al. Mutations in the sarcomere gene MYH7 in Ebstein anomaly. Circ. Cardiovasc. Genet. 4, 43-50 (2011).
19. Mefford, H. C., Sharp, A. J., Baker, C., Itsara, A., Jiang, Z., Buysse, K., et al. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N. Engl. J. Med. 359, 1685-1699 (2008).
20. Gourdie, R. G., Severs, N. J., Green, C. R., Rothery, S., Germroth, P., & Thompson, R. P. The spatial distribution and relative abundance of gap-junctional connexin40 and connexin43 correlate to functional properties of components of the cardiac atrioventricular conduction system. J. Cell Sci. 105, 985-991 (1993).
21. Gros, D., Jarry-Guichard, T., Ten Velde, I., De Maziere, A., Van Kempen, M. J., Davoust, J., et al. Restricted distribution of connexin40, a gap junctional protein, in mammalian heart. Circ. Res. 74, 839-851 (1994).
22. Ou, Z., Berg, J. S., Yonath, H., Enciso, V. B., Miller, D. T., Picker, J., et al. Microduplications of 22q11.2 are frequently inherited and are associated with variable phenotypes. Genet. Med. 10, 267-277 (2008).
23. Soemedi, R., Topf, A., Wilson, I. J., Darlay, R., Rahman, T., Glen, E., et al. Phenotypespecific effect of chromosome 1q21.1 rearrangements and GJA5 duplications in 2436 congenital heart disease patients and 6760 controls. Hum. Mol. Genet. 21, 1513-1520 (2012).
24. Gu, H., Smith, F. C., Taffet, S. M., & Delmar, M. High incidence of cardiac malformations in connexin40-deficient mice. Circ. Res. 93, 201-206 (2003).
25. Breckpot, J., Thienpont, B., Arens, Y., Tranchevent, L. C., Vermeesch, J. R., Moreau, Y., et al. Challenges of interpreting copy number variation in syndromic and non-syndromic congenital heart defects. Cytogenet. Genome Res. 135, 251-259 (2011).
26. Goldmuntz, E., Paluru, P., Glessner, J., Hakonarson, H., Biegel, J. A., White, P. S., et al. Microdeletions and microduplications in patients with congenital heart disease and multiple congenital anomalies. Congenit. Heart Dis. 6, 592-602
27. Lalani, S. R., Shaw, C., Wang, X., Patel, A., Patterson, L. W., Kolodziejska, K., et al. Rare DNA copy number variants in cardiovascular malformations with extracardiac abnormalities. Eur. J. Hum. Genet. 21, 173-181 (2013).
28. Thienpont, B., Mertens, L., De Ravel, T., Eyskens, B., Boshoff, D., Maas, N., et al. Submicroscopic chromosomal imbalances detected by array-CGH are a frequent cause of congenital heart defects in selected patients. Eur. Heart J. 28, 2778-2784 (2007).
29. Tomita-Mitchell, A., Mahnke, D. K., Struble, C. A., Tuffnell, M. E., Stamm, K. D., Hidestrand, M., et al. Human gene copy number spectra analysis in congenital heart malformations. Physiol. Genomics 44, 518-541 (2012).
30. Greenway, S. C., Pereira, A. C., Lin, J. C., DePalma, S. R., Israel, S. J., Mesquita, S. M., et al. De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nat. Genet. 41, 931-935 (2009).
31. Silversides, C. K., Lionel, A. C., Costain, G., Merico, D., Migita, O., Liu, B., et al. Rare copy number variations in adults with tetralogy of Fallot implicate novel risk gene pathways. PLoS Genet. 8, e1002843 (2012).
32. Soemedi, R., Wilson, I. J., Bentham, J., Darlay, R., Töpf, A., Zelenika, D., et al. Contribution of global rare copy-number variants to the risk of sporadic congenital heart disease. Am. J. Hum. Genet. 91, 489-501 (2012).
33. Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485, 237-241 (2012).
34. Boycott, K. M., Vanstone, M. R., Bulman, D. E., & MacKenzie, A. E. Rare-disease genetics in the era of next-generation sequencing: discovery to translation. Nat. Rev. Genet. 14, 681-691 (2013).
35. Marsman, R. F., Tan, H. L., & Bezzina, C. R. Genetics of sudden cardiac death caused by ventricular arrhythmias. Nat. Rev. Cardiol. 11, 96-111 (2014).
36. Zaidi, S., Choi, M., Wakimoto, H., Ma, L., Jiang, J., Overton, J. D., et al. De novo mutations in histone-modifying genes in congenital heart disease. Nature 498, 220-223 (2013).
37. Al Turki, S., Manickaraj, A. K., Mercer, C. L., Gerety, S. S., Hitz, M.-P., Lindsay, S., et al. Rare variants in NR2F2 cause congenital heart defects in humans. Am. J. Hum. Genet. 94, 574-585 (2014).
38. Wu, S., Cheng, C.-M., Lanz, R. B., Wang, T., Respress, J. L., Ather, S., et al. Atrial identity is determined by a COUP-TFII regulatory network. Dev. Cell 25, 417-426 (2013).
39. Chetaille, P., Preuss, C., Burkhard, S., Côté, J.-M., Houde, C., Castilloux, J., et al. Mutations in SGOL1 cause a novel cohesinopathy affecting heart and gut rhythm. Nat. Genet. 46, 1245-1249 (2014).
40. Bainbridge, M. N., Davis, E. E., Choi, W.-Y., Dickson, A., Martinez, H. R., Wang, M., et al. Loss of function mutations in NNT are associated with left ventricular noncompaction. Circ. Cardiovasc. Genet. (e-pub ahead of print 29 May 2015; doi: 10.1161/CIRCGENETICS. 115.001026).
41. Andelfinger, G. Next-generation sequencing in congenital heart disease: do new brooms sweep clean?. J. Am. Coll. Cardiol. 64, 2507-2509 (2014).
42. Arrington, C. B., Bleyl, S. B., Matsunami, N., Bonnell, G. D., Otterud, B. E. M., Nielsen, D. C., et al. Exome analysis of a family with pleiotropic congenital heart disease. Circ. Cardiovasc. Genet. 5, 175-182 (2012).
43. Martin, L. J., Pilipenko, V., Kaufman, K. M., Cripe, L., Kottyan, L. C., Keddache, M., et al. Whole exome sequencing for familial bicuspid aortic valve identifies putative variants. Circ. Cardiovasc. Genet. 7, 677-683 (2014).
44. Parrott, A., & Ware, S. M. The Role of the Geneticist and Genetic Counselor in an ACHD Clinic. Prog. Pediatr. Cardiol. 34, 15-20 (2012).
45. Cordell, H. J., Topf, A., Mamasoula, C., Postma, A. V., Bentham, J., Zelenika, D., et al. Genome-wide association study identifies loci on 12q24 and 13q32 associated with Tetralogy of Fallot. Hum. Mol. Genet. 22, 1473-1481 (2013).
46. Cordell, H. J., Bentham, J., Topf, A., Zelenika, D., Heath, S., Mamasoula, C., et al. Genome-wide association study of multiple congenital heart disease phenotypes identifies a susceptibility locus for atrial septal defect at chromosome 4p16. Nat. Genet. 45, 822-824 (2013).
47. Hu, Z., Shi, Y., Mo, X., Xu, J., Zhao, B., Lin, Y., et al. A genome-wide association study identifies two risk loci for congenital heart malformations in Han Chinese populations. Nat. Genet. 45, 818-821 (2013).
48. Bernstein, B. E., Birney, E., Dunham, I., Green, E. D., Gunter, C., & Snyder, M. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012).
49. De Laat, W., & Duboule, D. Topology of mammalian developmental enhancers and their regulatory landscapes. Nature 502, 499-506 (2013).
50. Shlyueva, D., Stampfel, G., & Stark, A. Transcriptional enhancers: from properties to genome-wide predictions. Nat. Rev. Genet. 15, 272-286 (2014).
51. Robertson, G., Hirst, M., Bainbridge, M., Bilenky, M., Zhao, Y., Zeng, T., et al. Genomewide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat. Methods 4, 651-657 (2007).
52. Tsompana, M., & Buck, M J. Chromatin accessibility: a window into the genome. Epigenetics Chromatin 7, 33 (2014).
53. Weintraub, H., & Groudine, M. Chromosomal subunits in active genes have an altered conformation. Science 193, 848-856 (1976).
54. John, S., Sabo, P. J., Thurman, R. E., Sung, M.-H., Biddie, S. C., Johnson, T. A., et al. Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat. Genet. 43, 264-268 (2011).
55. Thurman, R. E., Rynes, E., Humbert, R., Vierstra, J., Maurano, M. T., Haugen, E., et al. The accessible chromatin landscape of the human genome. Nature 489, 75-82 (2012).
56. Neph, S., Vierstra, J., Stergachis, A. B., Reynolds, A. P., Haugen, E., Vernot, B., et al. An expansive human regulatory lexicon encoded in transcription factor footprints. Nature 489, 83-90 (2012).
57. Boyle, A. P., Davis, S., Shulha, H. P., Meltzer, P., Margulies, E. H., Weng, Z., et al. High-resolution mapping and characterization of open chromatin across the genome. Cell 132, 311-322 (2008).
58. Goryshin, I. Y., & Reznikoff, W. S. Tn5 in vitro transposition. J. Biol. Chem. 273, 7367-7374 (1998).
59. Adey, A., Morrison, H. G., Asan, Xun, X., Kitzman, J. O., Turner, E. H., et al. Rapid, lowinput, low-bias construction of shotgun fragment libraries by high-density in vitro transposition. Genome Biol. 11, R119 (2010).
60. Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y., & Greenleaf, W. J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213-1218 (2013).
61. Manning, L., Heckscher, E. S., Purice, M. D., Roberts, J., Bennett, A. L., Kroll, J. R., et al. A resource for manipulating gene expression and analyzing cisregulatory modules in the Drosophila CNS. Cell Rep. 2, 1002-1013 (2012).
62. Visel, A., Taher, L., Girgis, H., May, D., Golonzhka, O., Hoch, R. V., et al. A high-resolution enhancer atlas of the developing telencephalon. Cell 152, 895-908 (2013).
63. Arnold, C. D., Gerlach, D., Stelzer, C., Boryn LM, Rath, M., & Stark, A. Genome-wide quantitative enhancer activity maps identified by STARR-seq. Science 339, 1074-1077 (2013).
64. De Wit, E., & De Laat, W. A decade of 3C technologies: insights into nuclear organization. Genes Dev. 26, 11-24 (2012).
65. Jin, F., Li, Y., Dixon, J. R., Selvaraj, S., Ye, Z., Lee, A. Y., et al. A high-resolution map of the three-dimensional chromatin interactome in human cells. Nature 503, 290-294 (2013).
66. Haberle, V., & Lenhard, B. Dissecting genomic regulatory elements in vivo. Nat. Biotechnol. 30, 504-506 (2012).
67. Lahm, H., Schön, P., Doppler, S., Dreβen, M., Cleuziou, J., Deutsch, M.-A., et al. Tetralogy of fallot and hypoplastic left heart syndrome-complex clinical phenotypes meet complex genetic networks. Curr. Genomics 16, 141-158 (2015).
68. Christoffels, V. M., Smits, G. J., Kispert, A., & Moorman, A. F. Development of the pacemaker tissues of the heart. Circ. Res. 106, 240-254 (2010).
69. Bamshad, M., Lin, R. C., Law, D. J., Watkins, W. C., Krakowiak, P. A., Moore, M. E., et al. Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome. Nat. Genet. 16, 311-315 (1997).
70. Meneghini, V., Odent, S., Platonova, N., Egeo, A., & Merlo, G. R. Novel TBX3 mutation data in families with Ulnar-Mammary syndrome indicate a genotype-phenotype relationship: mutations that do not disrupt the T-domain are associated with less severe limb defects. Eur. J. Med. Genet. 49, 151-158 (2006).
71. Barnett, P., & Postma, A. V. Molecular genetics of Holt-Oram syndrome. eLS 256, 799-804 (2014).
72. Frank, D U., Emechebe, U., Thomas, K. R., & Moon, A. M. Mouse TBX3 mutants suggest novel molecular mechanisms for Ulnar-mammary syndrome. PLoS One 8, e67841 (2013).
73. Arnolds, D. E., Liu, F., Fahrenbach, J. P., Kim, G. H., Schillinger, K. J., Smemo, S., et al. TBX5 drives Scn5a expression to regulate cardiac conduction system function. J. Clin. Invest. 122, 2509-2518 (2012).
74. Holm, H., Gudbjartsson, D. F., Arnar, D. O., Thorleifsson, G., Thorgeirsson, G., Stefansdottir, H., et al. Several common variants modulate heart rate, PR interval and QRS duration. Nat. Genet. 42, 117-122 (2010).
75. Pfeufer, A., Van Noord, C., Marciante, K. D., Arking, D. E., Larson, M. G., Smith, A. V., et al. Genome-wide association study of PR interval. Nat. Genet. 42, 153-159 (2010).
76. Sotoodehnia, N., Isaacs, A., De Bakker, P. I., Dorr, M., Newton-Cheh, C., Nolte, I.M., et al. Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat. Genet. 42, 1068-1076 (2010).
77. Van den Boogaard, M., Wong, L. Y. E., Tessadori, F., Bakker, M. L., Dreizehnter, L. K., Wakker, V., et al. Genetic variation in T-box binding element functionally affects SCN5A/ SCN10A enhancer. J. Clin. Invest. 122, 2519-2530 (2012).
78. Van den Boogaard, M., Smemo, S., Burnicka-Turek, O., Arnolds, D. E., Van De Werken, H. J. G., Klous, P., et al. A common genetic variant within SCN10A modulates cardiac SCN5A expression. J. Clin. Invest. 124, 1844-1852 (2014).
79. Lettice, L. A., Heaney, S. J. H., Purdie, L. A., Li, L., De Beer, P., Oostra, B. A., et al. A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. Hum. Mol. Genet. 12, 1725-1735 (2003).
80. Weedon, M. N., Cebola, I., Patch, A.-M., Flanagan, S. E., De Franco, E., Caswell, R., et al. Recessive mutations in a distal PTF1A enhancer cause isolated pancreatic agenesis. Nat. Genet. 46, 61-64 (2014).
81. Smemo, S., Campos, L. C., Moskowitz, I. P., Krieger, J. E., Pereira, A. C., & Nobrega, M. A. Regulatory variation in a TBX5 enhancer leads to isolated congenital heart disease. Hum. Mol. Genet. 21, 3255-3263 (2012).
82. Tian, Y., Yuan, L., Goss, A. M., Wang, T., Yang, J., Lepore, J. J., et al. Characterization and in vivo pharmacological rescue of a Wnt2-Gata6 pathway required for cardiac inflow tract development. Dev. Cell 18, 275-287 (2010).